19.69 USD
↘ 0.45 (2.24%)LIVE (AS OF 02:00 PM EST)
Shares of NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) are trading at $19.69. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, NAMS is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 13, 2026.